COVID-19 | Clínica -diagnóstico y tratamiento
- Systemic Inflammatory Response Syndrome Is a Major Contributor to COVID-19–Associated Coagulopathy
- COVID-19 cardiac injury: Implications for long-term surveillance and outcomes in survivors
- Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19)
- Heart and Lung Multimodality Imaging in COVID-19
- Cardiac Involvement in Patients Recovered From COVID-2019 Identified Using Magnetic Resonance Imaging
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
- Experiencia en el manejo de pacientes graves con COVID-19 en una unidad de terapia intensiva
- Revista Medicina Interna
- Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
- Massachusetts General Hospital (MGH) COVID-19 Treatment Guidance
- Recomendaciones para el tratamiento de SARS-CoV2
- Manual COVID Pediatría
- Genomewide Association Study of Severe Covid-19 with Respiratory Failure
- COVID-19, SARS CoV-2
- Guía Farmacoterapéutica COVID-19
- Algoritmos interinos para la atención del COVID-19
- Guía de criterios éticos ante emergencias sanitarias en México en el contexto de la pandemia por COVID-19
- Imagen tomográfica de COVID-19
- Actualidades de COVID-19
- Angiotensin‑converting enzyme 2
- COVID Hemodialisis en Mexico
- COVID 19 DRUG Therapy
- Internatinal Pulmonologist Consensus COVID-19
- Síndrome RITAC
- COVID-19 – Attacks the 1-Beta Chain of Hemoglobin and Captures thePorphyrin to Inhibit Human Heme Metabolism
- Protocolo tratamiento del pacinte COVID -19 según gravedad y evolución
- COVID Reference
- Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID‑19)
- Face masks for the public during the covid-19 crisis
- Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)
- Consenso Colombiano COVID 19
- Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
- Tromboprofilaxis COVID 19
- Manejo COVID-19 Hospital Universitario de Fuenlabrada
- Posicionamiento sobre medicamentos antihipertensivos y COVID-19
- Medicina Interna SUP 22020 completo
- OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.
- Inclusión de la Ivermectina en la primera línea de acción terapéutica para COVID-19
- Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
- Manual General COVID-19 Hospitalización
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
- Experiencia en el manejo de pacientes graves con COVID-19 en una unidad de terapia intensiva
- Revista Medicina Interna
- Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
- Massachusetts General Hospital (MGH) COVID-19 Treatment Guidance
- Recomendaciones para el tratamiento de SARS-CoV2
- Manual COVID Pediatría
- Genomewide Association Study of Severe Covid-19 with Respiratory Failure
- COVID-19, SARS CoV-2
- Guía Farmacoterapéutica COVID-19
- Algoritmos interinos para la atención del COVID-19
- Guía de criterios éticos ante emergencias sanitarias en México en el contexto de la pandemia por COVID-19
- Imagen tomográfica de COVID-19
- Actualidades de COVID-19
- Angiotensin‑converting enzyme 2
- COVID Hemodialisis en Mexico
- COVID 19 DRUG Therapy
- Internatinal Pulmonologist Consensus COVID-19
- Síndrome RITAC
- COVID-19 – Attacks the 1-Beta Chain of Hemoglobin and Captures thePorphyrin to Inhibit Human Heme Metabolism
- Protocolo tratamiento del pacinte COVID -19 según gravedad y evolución
- COVID Reference
- Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID‑19)
- Face masks for the public during the covid-19 crisis
- Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)
- Consenso Colombiano COVID 19
- Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
- Tromboprofilaxis COVID 19
- Manejo COVID-19 Hospital Universitario de Fuenlabrada
- Posicionamiento sobre medicamentos antihipertensivos y COVID-19
- Medicina Interna SUP 22020 completo
- OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.
- Inclusión de la Ivermectina en la primera línea de acción terapéutica para COVID-19
- Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
- Manual General COVID-19 Hospitalización
- Guías de manejo antocoagulación COVID
- COVID VMI
- Protocolo de posición prono en paciente consciente con falla respiratoria aguda por COVID-19
- Escalas NAC y COVID-19 Urgencias
- Protocolo de atención en pisos de Medicina Interna para pacientes con COVID-19
- Algoritmo COVID Abril Nutri
- Coagulopathy associated with COVID-19
- Clinical Practice – Severe COVID-19
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
- Experiencia en el manejo de pacientes graves con COVID-19 en una unidad de terapia intensiva
- Revista Medicina Interna
- Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
- Massachusetts General Hospital (MGH) COVID-19 Treatment Guidance
- Recomendaciones para el tratamiento de SARS-CoV2
- Manual COVID Pediatría
- Genomewide Association Study of Severe Covid-19 with Respiratory Failure
- COVID-19, SARS CoV-2
- Guía Farmacoterapéutica COVID-19
- Algoritmos interinos para la atención del COVID-19
- Guía de criterios éticos ante emergencias sanitarias en México en el contexto de la pandemia por COVID-19
- Imagen tomográfica de COVID-19
- Actualidades de COVID-19
- Angiotensin‑converting enzyme 2
- COVID Hemodialisis en Mexico
- COVID 19 DRUG Therapy
- Internatinal Pulmonologist Consensus COVID-19
- Síndrome RITAC
- COVID-19 – Attacks the 1-Beta Chain of Hemoglobin and Captures thePorphyrin to Inhibit Human Heme Metabolism
- Protocolo tratamiento del pacinte COVID -19 según gravedad y evolución
- COVID Reference
- Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID‑19)
- Face masks for the public during the covid-19 crisis
- Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)
- Consenso Colombiano COVID 19
- Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
- Tromboprofilaxis COVID 19
- Manejo COVID-19 Hospital Universitario de Fuenlabrada
- Posicionamiento sobre medicamentos antihipertensivos y COVID-19
- Medicina Interna SUP 22020 completo
- OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.
- Inclusión de la Ivermectina en la primera línea de acción terapéutica para COVID-19
- Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
- Manual General COVID-19 Hospitalización
- Guías de manejo antocoagulación COVID
- COVID VMI
- Protocolo de posición prono en paciente consciente con falla respiratoria aguda por COVID-19
- Escalas NAC y COVID-19 Urgencias
- Protocolo de atención en pisos de Medicina Interna para pacientes con COVID-19
- Algoritmo COVID Abril Nutri
- Coagulopathy associated with COVID-19
- Clinical Practice – Severe COVID-19
- Early Safety Indicators of COVID-19 Convalescent Plasma in 5,000 Patients